Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study.
- Authors
- Loriot, Y[Loriot, Yohann]; Grivas, P[Grivas, Petros]; De Wit, R[De Wit, Ronald]; Balar, AV[Balar, Arjun Vasant]; Siefker-Radtke, AO[Siefker-Radtke, Arlene O.]; Zolnierek, J[Zolnierek, Jakub]; Csoszi, T[Csoszi, Tibor]; Shin, SJ[Shin, Sang Joon]; Park, SH[Park, Se Hoon]; Atduev, V[Atduev, Vagif]; Gumus, M[Gumus, Mahmut]; Su, YL[Su, Yu-Li]; Karaca, SB[Karaca, Saziye Burcak]; Cutuli, H[Cutuli, Hernan]; Sendur, MN[Sendur, Mehmet Nahit]; Jia, C[Jia, Calvin]; O'Hara, K[O'Hara, Karen]; Franco, S[Franco, Sonia]; Matsubara, N[Matsubara, Nobuaki]
- Issue Date
- 20-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.6
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 6
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.